Four bisphosphonates are used for the treatment of metastatic bone disease: clodronate,
which is available outside the United States in both intravenous and oral formulations; …

Introduction Evidence from a number of open-label, uncontrolled studies has suggested that
rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-…

Sarcoidosis is an immunemediated disease of unknown cause, characterized by noncaseating
epithelioid granulomas, affecting multiple organs. Clinically apparent renal involvement …

Objective. Differentiating gout, calcium pyrophosphate deposition disease (CPPD), and non–crystal-related
inflammatory arthropathies (non-CRA) is essential but often clinically …

Background The treatment of giant cell arteritis with glucocorticoid-sparing agents is an
unmet medical need. We evaluated the efficacy and safety of secukinumab, an anti-interleukin-…

Methods: Dynamic positron emission tomography (PET) studies with F-18-deoxyglucose
were performed in patients with multiple myeloma who received anthracycline-based …

1 Regierer AC, Hasseli R, Schäfer M, et al. TNFi is associated with positive outcome, but JAKi
and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients …

Objective. To describe nailfold videocapillaroscopy (NVC) features of patients with antisynthetase
syndrome (AS) and to investigate possible correlations with clinical and serological …

If systematically screened for renal manifestations are likely to occur in up to 25–30% of all
sarcoidosis patients. The most common histological form of renal sarcoidosis is the …

Large-vessel vasculitis (LVV) is a group of diseases mainly comprised of giant-cell arteritis (GCA),
Takayasu arteritis, and a series of rare diseases like Behçet’s disease, IgG4-related …